Your browser doesn't support javascript.
loading
Clinical Immunogenicity Evaluation of Eptinezumab, a Therapeutic Humanized Monoclonal Antibody Targeting Calcitonin Gene-Related Peptide (CGRP) for the Preventive Treatment of Migraine.
Pederson, Susan; Biondi, David M; Allan, Brent; Cady, Roger; Schaeffler, Barbara; Baker, Brian; Latham, John.
Affiliation
  • Pederson S; Lundbeck Seattle BioPharmaceuticals, Inc., Bothell, WA, United States.
  • Biondi DM; Alder BioPharmaceuticals, Inc. (CKA Lundbeck Seattle BioPharmaceuticals, Inc.), Bothell, WA, United States.
  • Allan B; Alder BioPharmaceuticals, Inc. (CKA Lundbeck Seattle BioPharmaceuticals, Inc.), Bothell, WA, United States.
  • Cady R; Lundbeck Seattle BioPharmaceuticals, Inc., Bothell, WA, United States.
  • Schaeffler B; Lundbeck Seattle BioPharmaceuticals, Inc., Bothell, WA, United States.
  • Baker B; Lundbeck Seattle BioPharmaceuticals, Inc., Bothell, WA, United States.
  • Latham J; Alder BioPharmaceuticals, Inc. (CKA Lundbeck Seattle BioPharmaceuticals, Inc.), Bothell, WA, United States.
Front Immunol ; 12: 765822, 2021.
Article in En | MEDLINE | ID: mdl-34759933
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Calcitonin Gene-Related Peptide / Antibodies, Monoclonal, Humanized / Migraine Disorders / Antibodies Type of study: Clinical_trials Limits: Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Calcitonin Gene-Related Peptide / Antibodies, Monoclonal, Humanized / Migraine Disorders / Antibodies Type of study: Clinical_trials Limits: Humans Language: En Journal: Front Immunol Year: 2021 Document type: Article